Clinical Outcomes of Preservation Versus Resection of Portal/Superior Mesenteric Vein During Pancreaticoduodenectomy in Pancreatic Cancer Patients Who Respond to Neoadjuvant Treatment
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seoul National University Hospital
Age
0–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pancreatic head cancer patients who underwent surgery after neoadjuvant treatment between January 2012 and December 2022 at Seoul National University Hospital
You may not be if
Metastatic unresectable and locally advanced pancreatic cancer
Resectable pancreatic cancer without portal/superior mesenteric vein invasion
Cancer aggravation after neoadjuvant treatment
Portal/superior mesenteric vein encasing and narrowing after neoadjuvant treatment
Patients who underwent palliative surgery
Non-pancreatic ductal adenocarcinoma patients
Patients who death within 30 days of surgery
Loss of follow-up patients
Patients who underwent resection for suspected main artery and adjacent organ invasion
Clareo Health | Clinical Outcomes of Preservation Versus Resection of Portal/Superior Mesenteric Vein During Pancreaticoduodenectomy in Pancreatic Cancer Patients Who Respond to Neoadjuvant Treatment
